262 related articles for article (PubMed ID: 26121234)
1. Role of Nongenomic Signaling Pathways Activated by Aldosterone During Cardiac Reperfusion Injury.
Ashton AW; Le TY; Gomez-Sanchez CE; Morel-Kopp MC; McWhinney B; Hudson A; Mihailidou AS
Mol Endocrinol; 2015 Aug; 29(8):1144-55. PubMed ID: 26121234
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition.
Maning J; McCrink KA; Pollard CM; Desimine VL; Ghandour J; Perez A; Cora N; Ferraino KE; Parker BM; Brill AR; Aukszi B; Lymperopoulos A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326036
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone's rapid, nongenomic effects are mediated by striatin: a modulator of aldosterone's effect on estrogen action.
Coutinho P; Vega C; Pojoga LH; Rivera A; Prado GN; Yao TM; Adler G; Torres-Grajales M; Maldonado ER; Ramos-Rivera A; Williams JS; Williams G; Romero JR
Endocrinology; 2014 Jun; 155(6):2233-43. PubMed ID: 24654783
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone activates Na+/H+ exchange in vascular smooth muscle cells by nongenomic and genomic mechanisms.
Ebata S; Muto S; Okada K; Nemoto J; Amemiya M; Saito T; Asano Y
Kidney Int; 1999 Oct; 56(4):1400-12. PubMed ID: 10504492
[TBL] [Abstract][Full Text] [Related]
5. Early nongenomic events in aldosterone action in renal collecting duct cells: PKCalpha activation, mineralocorticoid receptor phosphorylation, and cross-talk with the genomic response.
Le Moëllic C; Ouvrard-Pascaud A; Capurro C; Cluzeaud F; Fay M; Jaisser F; Farman N; Blot-Chabaud M
J Am Soc Nephrol; 2004 May; 15(5):1145-60. PubMed ID: 15100355
[TBL] [Abstract][Full Text] [Related]
6. Striatin heterozygous mice are more sensitive to aldosterone-induced injury.
Garza AE; Trefts E; Katayama Rangel IA; Brooks D; Baudrand R; Moize B; Romero JR; Ranjit S; Treesaranuwattana T; Yao TM; Adler GK; Pojoga LH; Williams GH
J Endocrinol; 2020 Jun; 245(3):439-450. PubMed ID: 32229698
[TBL] [Abstract][Full Text] [Related]
7. Activation of the mineralocorticoid receptor increases striatin levels.
Pojoga LH; Coutinho P; Rivera A; Yao TM; Maldonado ER; Youte R; Adler GK; Williams J; Turchin A; Williams GH; Romero JR
Am J Hypertens; 2012 Feb; 25(2):243-9. PubMed ID: 22089104
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction.
Mihailidou AS; Loan Le TY; Mardini M; Funder JW
Hypertension; 2009 Dec; 54(6):1306-12. PubMed ID: 19841288
[TBL] [Abstract][Full Text] [Related]
9. Activation of the aldosterone/mineralocorticoid receptor system and protective effects of mineralocorticoid receptor antagonism in retinal ischemia-reperfusion injury.
Liu Y; Hirooka K; Nishiyama A; Lei B; Nakamura T; Itano T; Fujita T; Zhang J; Shiraga F
Exp Eye Res; 2012 Mar; 96(1):116-23. PubMed ID: 22200488
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone induces rapid sodium intake by a nongenomic mechanism in the nucleus tractus solitarius.
Qiao H; Hu B; Zhou H; Yan J; Jia R; Lu B; Sun B; Luo X; Fan Y; Wang N
Sci Rep; 2016 Dec; 6():38631. PubMed ID: 27934887
[TBL] [Abstract][Full Text] [Related]
11. The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes.
Gravez B; Tarjus A; Jimenez-Canino R; El Moghrabi S; Messaoudi S; Alvarez de la Rosa D; Jaisser F
PLoS One; 2013; 8(9):e73737. PubMed ID: 24040049
[TBL] [Abstract][Full Text] [Related]
12. AT1 and aldosterone receptors blockade prevents the chronic effect of nandrolone on the exercise-induced cardioprotection in perfused rat heart subjected to ischemia and reperfusion.
Marques-Neto SR; Ferraz EB; Rodrigues DC; Njaine B; Rondinelli E; Campos de Carvalho AC; Nascimento JH
Cardiovasc Drugs Ther; 2014 Apr; 28(2):125-35. PubMed ID: 24258356
[TBL] [Abstract][Full Text] [Related]
13. Spironolactone suppresses aldosterone-induced Kv1.5 expression by attenuating mineralocorticoid receptor-Nox1/2/4-mediated ROS generation in neonatal rat atrial myocytes.
Lu G; Li J; Zhai Y; Li Q; Xie D; Zhang J; Xiao Y; Gao X
Biochem Biophys Res Commun; 2019 Dec; 520(2):379-384. PubMed ID: 31606204
[TBL] [Abstract][Full Text] [Related]
14. Low-dose spironolactone prevents apoptosis repressor with caspase recruitment domain degradation during myocardial infarction.
Loan Le TY; Mardini M; Howell VM; Funder JW; Ashton AW; Mihailidou AS
Hypertension; 2012 Jun; 59(6):1164-9. PubMed ID: 22508833
[TBL] [Abstract][Full Text] [Related]
15. Action of ANP on the nongenomic dose-dependent biphasic effect of aldosterone on NHE1 in proximal S3 segment.
Braga-Sobrinho C; Leite-Dellova DC; Mello-Aires M
J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):89-97. PubMed ID: 22154810
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone Rapidly Enhances Levels of the Striatin and Caveolin-1 Proteins in Rat Kidney: The Role of the Mineralocorticoid Receptor.
Inthachart K; Manotham K; Eiam-Ong S; Eiam-Ong S
Endocrinol Metab (Seoul); 2019 Sep; 34(3):291-301. PubMed ID: 31565882
[TBL] [Abstract][Full Text] [Related]
17. Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension.
Xue B; Beltz TG; Yu Y; Guo F; Gomez-Sanchez CE; Hay M; Johnson AK
Am J Physiol Heart Circ Physiol; 2011 Feb; 300(2):H555-64. PubMed ID: 21112947
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation.
Gros R; Ding Q; Liu B; Chorazyczewski J; Feldman RD
Am J Physiol Cell Physiol; 2013 Mar; 304(6):C532-40. PubMed ID: 23283935
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone aggravates glucose intolerance induced by high fructose.
Sherajee SJ; Rafiq K; Nakano D; Mori H; Kobara H; Hitomi H; Fujisawa Y; Kobori H; Masaki T; Nishiyama A
Eur J Pharmacol; 2013 Nov; 720(1-3):63-8. PubMed ID: 24201309
[TBL] [Abstract][Full Text] [Related]
20. Nongenomic vascular action of aldosterone in the glomerular microcirculation.
Arima S; Kohagura K; Xu HL; Sugawara A; Abe T; Satoh F; Takeuchi K; Ito S
J Am Soc Nephrol; 2003 Sep; 14(9):2255-63. PubMed ID: 12937301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]